Results 21 to 30 of about 485,993 (264)
EGFR mutation testing in non-small cell lung cancer (NSCLC)
Journal of Infection and Public Health, 2012 Summary: Lung carcinoma is subdivided into small cell carcinoma and non-small cell carcinoma (NSCLC). NSCLC is heterogeneous group of carcinomas and accounts for 70–80% of lung cancer. NSCLC is further divided into adenocarcinoma, squamous cell carcinoma,
Fouad Al Dayel
doaj +1 more source
Respiratory Medicine Case Reports, 2020 Pulmonary pleomorphic carcinoma (PPC) is a poorly differentiated non-small cell lung carcinoma, including squamous cell carcinoma, adenocarcinoma, or undifferentiated non-small cell lung carcinoma with at least 10% spindle and/or giant cells.
Jae-Han Jeong +3 more
doaj +1 more source
Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer. [PDF]
PLoS ONE, 2011 Squamous cell lung carcinomas account for approximately 25% of new lung carcinoma cases and 40,000 deaths per year in the United States. Although there are multiple genomically targeted therapies for lung adenocarcinoma, none has yet been reported in ...
Amit Dutt +11 more
doaj +1 more source
Journal of Medical Case Reports, 2019 Background Primary small cell carcinoma of the kidney is an extremely rare neoplasm. The clinical features of small cell carcinoma of the kidney are not well established due to its rarity and scarcity of case reports.
Charles Chu +3 more
doaj +1 more source
Combined small-cell lung carcinoma
OncoTargets and Therapy, 2018 Currently, studies assessing combined small-cell lung carcinoma (C-SCLC) are relatively scarce and limited. Indeed the clinicopathological features, treatment, and prognosis of patients with C-SCLC have not been fully determined. The incidence of C-SCLC ranges from 5%-28% in different studies, which is related to the specimen types used.
Jing Qin, Hongyang Lu
openaire +4 more sources
Medical Journal of Babylon, 2018 Background: Lung cancer (LC) is the most common fatal malignant neoplasm worldwide, especially in developing countries. Objective: The objective of this study was to evaluate the correlation between radiological and clinicopathological findings of the LC.
Zahir Salih Hussein +1 more
doaj +1 more source
Technology in Cancer Research & Treatment, 2021 Background and Objective: Small cell lung cancer (SCLC) is characterized by rapid growth, strong invasion, and early metastasis. However, the cause of its occurrence remains unclear.
Di-Jia Zou MD +5 more
doaj +1 more source
A Case Report of Small Cell Lung Carcinoma in a Patient with Progressive Diffuse Sclerosis
Journal of Mazandaran University of Medical Sciences, 2022 Connective tissue diseases, including scleroderma, may be associated with an increased risk of lung cancer. The most common type of lung cancer associated with systemic sclerosis is adenocarcinoma or bronchoalveolar carcinoma, and small cell carcinoma is
Hojatolah Ghorbani +4 more
doaj
Chinese Journal of Lung Cancer, 2022 Treatment of advanced non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutation with EGFR-tyrosine kinase inhibitors (EGFR-TKIs) can achieve good disease control, but it will inevitably produce drug resistance ...
Jieqiong WU +5 more
doaj +1 more source
Gastric metastasis by lung small cell carcinoma
World Journal of Gastroenterology, 2006 Metastatic tumors of the gastrointestinal tract are rare. We describe a case of gastric metastasis due to primary lung cancer, revealed by an upper gastrointestinal endoscopy (UGIE). Haematogenous metastases to the stomach are a rare event. To our knowledge, only 55 cases have been described in the international literature.
G. CASELLA +7 more
openaire +3 more sources